menu
The modular facilities market is estimated to be worth USD 6.4 billion in 2030.
Off-site, modular construction minimizes disruption tobuilding timelines and logistical delays, ensuring systematic delivery of new facilities,

Off-site, modular construction minimizes disruption tobuilding timelines and logistical delays, ensuring systematic delivery of new facilities,this is particularly beneficial within the healthcare industry, where speed,sanitation and sterility are crucial

 

Roots Analysis is pleased to announce the publication of its recentstudy, titled, “Modular Facilities inPharmaceutical and Biotechnology Market

 

The report featuresan extensive study of the current market landscape and future potential of theplayers engaged in offering services for modular facility construction forbiotechnology and pharmaceutical industries. The study presents an in-depthanalysis, highlighting the capabilities of various stakeholders engaged in thisdomain. Amongst other elements, the report features:

 

§ An in-depth review of the market landscape of players thatoffer services for modular facility construction for biotechnology andpharmaceutical industries, along with the details of certifications obtainedand COVID-19 related initiatives undertaken by modular service providers.

§ A review of the market landscape of modular cleanroomsalong with information on their year of establishment, company size, locationof headquarters, type of industry served, type of modular cleanrooms, type ofmodular cleanroom components. It also includes details related to regulatoryapprovals and certifications.

§ An analysis of the partnerships that have been inked bystakeholders in this domain, during the period between 2012 and 2021.

§ An in-depth analysis of modular projects undertaken acrosskey geographical regions, featuring information on type of facility, facilityarea, most active manufacturers, most active clients, location offacility. 

§ An insightful analysis on facility construction trends inthe pharmaceutical industry for the last five years, highlighting facilityconstruction projects established by top 20 pharma / biotech players.

§ Elaborate profiles of key players that provide a wide rangeof modular manufacturing solutions to pharmaceutical and biotechnologyindustries. 

§ An in-depth review of emerging trends, including processingtechnologies with modular facilities, the shift towards smaller,multi-purpose modular facilities, and technological advancements in modularconstruction processes.

§ A detailed discussion on the various growth drivers andtrends related to modular solutions in emerging markets by pharmaceutical /biopharmaceutical CMOs.

§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)

 

To Request Sample Pages - https://www.rootsanalysis.com/reports/178/request-sample.html

 

§ Type of Modular Construct 

§ Hybrid Skid

§ Plug-and-Play

§ Skid-Mounted

§ Truckable

§ Others

§ Type of Construction Component

§ Base Building

§ Electrical System

§ Mechanical System

§ Process Equipment

§ Process Piping

§ Process Utilities

§ Other Components

§ Purpose of Facility

§ Aseptic Filling

§ Manufacturing

§ Research and Development

§ Others

§ Facility Area

§ Very Small

§ Small

§ Mid-Sized

§ Large

§ Very Large

§ Scale of Operation

§ Clinical

§ Commercial

§ Type of Industry

§ Pharmaceutical                   

§ Biotechnology

§ Type of Product

§ Biosimilars             

§ Cell and Gene Therapies

§ Monoclonal Antibodies

§ Vaccines

§ Other Products

§ Type of Facility

§    New Facility

§    Facility Expansions

§ Key Geographical Regions

§ North America                    

§ Europe

§ Asia

§ Middle East and North Africa

§ Latin America

§ Rest of the World

 

Download Free Insights now - https://www.rootsanalysis.com/reports/178/free-insights.html

 

Transcripts of interviews held with the following seniorlevel representatives of stakeholder companies

Alan de Zayas(Modular Building Manufacturing and Construction Team, AvonModular Construction)

§ François Abiven (Executive Vice-President Global BusinessUnit BLS and Luca Mussati Vice President, Pharma and Biotech Life Sciences, Exyte)

§ Maik Jornitz (President and Chief Executive Officer, G-CON Manufacturing)

§ Pär Almhem (President, Modwave)

§ Sulogna Roy (Ex Sales Manager, Zeton)

§ Vernon Solomon (Specialist in Modular Design for Cleanroomsand Close Tolerance Temperature and Humidity Control, Environmental Systems Corporation)

 

Keycompanies covered in the report

§ Cytiva

§ G-CON Manufacturing

§ Pharmadule Morimatsu

§ NNE

§ IPM Technologies

§ KeyPlants

§ Germfree Laboratories

§ ModuleCO Pharma

 

Formore information, please click on the following link

https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

 

You may also be interested in the following titles:

1.      Vaccine Contract Manufacturing Market (3rd Edition)

2.      Biopharmaceutical CROs Market

3.    Continuous Manufacturing Equipment Providers Market,

4.    DNA-EncodedLibraries

5.    DeepLearning Market

6.    HumanFactors Engineering and Usability Testing Services Market

 

About Roots Analysis

Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com